FEDERAL UNIVERSITY OF JUIZ DE FORA - Brazil
AUTHOR PROFILE
SCOPUS
ORCID
EARLY ACADEMIC PURSUITS
Rodrigo Luiz Fabri began his academic journey with a strong foundation in the field of biological sciences. He completed his Bachelor's degree in Pharmacy in 2006, followed by a Master's degree in Biological Sciences in 2008 from the Universidade Federal de Juiz de Fora (UFJF). His academic excellence continued with a Ph.D. in Biological Sciences, specializing in Pharmacy and Pharmacognosy, awarded in 2013. During this period, he focused on research related to Mitracarpus frigidus, exploring its anti-inflammatory, schistosomicidal, and cytotoxic activities.
PROFESSIONAL ENDEAVORS
Dr. Fabri's professional journey showcases a commitment to academia and research. He has been associated with UFJF in various capacities, including as a government employee, PHARMACEUTICAL AREA collaborator, and lecturer. Notably, his roles have extended to membership in the Sociedade Brasileira de Farmacognosia (Brazilian Society of Pharmacognosy) and service as a collaborator at the Sociedade Brasileira de Farmacognosia.
Dr. Fabri's research has primarily focused on the pharmacological and toxicological aspects of plant extracts, with a significant emphasis on Mitracarpus frigidus. His investigations include the isolation and structural elucidation of bioactive compounds, evaluation of antimicrobial and leishmanicidal activities, and exploration of the potential therapeutic applications of natural products. His work contributes to the understanding of natural compounds for the development of novel drugs.
IMPACT AND INFLUENCE
As a researcher, Dr. Fabri has actively participated in numerous research projects, indicating his impact on advancing knowledge in pharmacognosy and related fields. His involvement in projects such as "Desenvolvimento De Formulações Nanotecnológicas Contendo Extrato De Mitracarpus Frigidus Como Tratamento De Candidíase E Infecções Secundárias Em Pacientes Críticos Com Covid-19" and "Atividade antifúngica de atorvastatina frente a uma espécie de Candida albicans resistente a multidrogas" demonstrates his commitment to addressing contemporary health challenges.
ACADEMIC CITATIONS
Dr. Fabri's academic contributions are evident through his involvement in teaching and mentoring activities. He has taught various courses, including Biochemistry, Pharmacology, and Genetics, showcasing his expertise in these domains. His academic PHARMACEUTICAL AREA endeavors extend beyond traditional classroom settings, involving participation in the "LIGA ACADÊMICA DE FARMACOLOGIA CLINICA E TERAPÊUTICAS NÃO CONVENCIONAIS EM MEDICINA VETERINÁRIA (LAFC-VET)," highlighting his commitment to fostering interdisciplinary approaches in education.
LEGACY AND FUTURE CONTRIBUTIONS
Dr. Rodrigo Luiz Fabri's legacy lies in his significant contributions to the understanding of medicinal plants, particularly Mitracarpus frigidus. His research has opened avenues for exploring natural compounds for therapeutic purposes. As a seasoned academician, his future contributions are anticipated to further enrich the fields of pharmacognosy, drug discovery, and education.
NOTABLE PUBLICATIONS
Antibiofilm potential of Annona muricata L. ethanolic extract against multi-drug resistant Candida albicans 2023(1)
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery 2023(1)
Supramolecular complexes between Plinia cauliflora (DC.) Kausel extracts and β-cyclodextrin 2023(1)
Antifungal Annona muricata L. (soursop) extract targets the cell envelope of multi-drug 2023(5)
Isolation and Chemical Characterization of Antifungal, Antioxidant, and Anti-Inflammatory 2023(1)